Home » Merck’s OTC Version of Zegerid Wins FDA Approval
Merck’s OTC Version of Zegerid Wins FDA Approval
On Tuesday, both Merck & Co. and Santarus Inc. confirmed that the former’s over-the-counter version of the latter’s
heartburn drug, Zegerid, to be marketed under the same name, has been awarded approval by the US Food and Drug Administration.
TopNews
TopNews
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May